DOI:
10.1055/s-00033990
TH Open
LinksClose Window
References
Graham DJ, Reichman ME, Wernecke M. et al.
Stroke, bleeding, and mortality risks in elderly medicare beneficiaries treated with dabigatran or rivaroxaban for nonvalvular atrial fibrillation.
JAMA Intern Med 2016;
176 (11) 1662-1671
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.